Filing Details

Accession Number:
0001562180-23-004746
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-06-02 17:03:03
Reporting Period:
2023-05-31
Accepted Time:
2023-06-02 17:03:03
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1831363 Terns Pharmaceuticals Inc. TERN () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1762316 Vel Senthil Sundaram C/O Terns Pharmaceuticals, Inc.
1065 East Hillsdale Blvd., Suite 100
Foster City CA 94404
Chief Executive Officer No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2023-05-31 2,111 $1.41 9,770 No 5 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 5 P Direct
Footnotes
  1. Includes the purchase of 2,111 shares under the Terns Employee Stock Purchase Plan on May 31, 2023.